(AP)—The 9th U.S. Circuit Court of Appeals says some Idaho abortion laws are likely unconstitutional, including one barring medication-induced abortions. But the judges didn't pass judgment on Idaho's fetal pain law, saying ...
Sep 11, 2012
0
0
A Sao Paulo court allowed a woman to abort a four-month-old malformed fetus despite Brazil law only granting abortions in cases of rape or when the mother's life is in danger, local media said Sunday.
Sep 3, 2012
1
0
(AP)—Italy's ban on screening embryos for diseases before they are implanted in a womb violates the rights of a couple whose first child was born with cystic fibrosis, the European Court of Human Rights ruled Tuesday.
Aug 28, 2012
0
0
(Medical Xpress) -- New University of Otago research into two sex hormones released by the testes of male fetuses and boys may help solve the enduring mystery of why autism is much more common in boys than girls.
Aug 15, 2012
3
0
Scientists at the California Institute of Technology (Caltech) pioneered the study of the link between irregularities in the immune system and neurodevelopmental disorders such as autism a decade ago. Since then, studies ...
Jul 17, 2012
0
0
Standing for long periods during pregnancy may curb the growth of the developing fetus, suggests research published online in Occupational and Environmental Medicine.
Jun 27, 2012
0
0
(Medical Xpress) -- Women pregnant with smaller-than-average fetuses may also need to worry about their long-term cardiovascular health risks, according to new research in the American Heart Association’s journal Hypertension.
Jun 27, 2012
0
0
Researchers from the Ottawa Hospital Research Institute (OHRI) and the University of Ottawa (uOttawa) have found a protein in the blood of pregnant women that can predict if they are likely to have a fetus that doesn't grow ...
Jun 21, 2012
0
0
The latest advance in prenatal genetic testing purports to offer parents more detailed information than ever about the child they are expecting. But for some, the new answers could lead to another round of questions.
Jun 20, 2012
0
0
(HealthDay) -- Perjeta (pertuzumab) has been approved by the U.S. Food and Drug Administration to treat people with HER2-positive late-stage breast cancer, the agency said in a news release.
Jun 11, 2012
0
0
